Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117344) titled 'Median effective dose of Ciprofol Combined with Remifentanil for Inhibiting Response to Gastroscopy in Elderly Patients' on Jan. 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Anhui Medical University
Condition:
Gastrointestinal diseases
Intervention:
A group: After the administration of remifentanil, inject the assigned dose of ciprofol within 30 seconds,the dose of ciprofol for the next patient will be determined based on the response of the previous patient to the insertion of the endoscope.
Recruitment Status: Not Recruiting
Phase: 4 ...